The present invention provides compounds of formula (I): ##STR00001## wherein all variables are as defined herein, pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.

 
Web www.patentalert.com

< Pyridine inhibitors of ERK2 and uses thereof

> (2S,4S)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-L-phenylalanyl]-2-pyrro- lidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof

~ 00482